The global stroke market was valued at BUSD 8 in 2018 according to Transparency Market Research2.
Projected to grow at a CAGR of 7 percent over the forecast period, the global stroke treatment market is expected to reach a value of approximately BUSD 15 by the year 2027.
A rise in the prevalence of stroke across the world, a surge in the elderly patient pool, and rapid rise in comorbidities such as COVID-19, atrial fibrillation, diabetes, and hypertension leading to high risk of developing stroke are anticipated to drive the global stroke treatment market during the forecast period.
North America is the leading regional market in the global stroke treatment market and will continue to have a major share throughout the forecast period of 2019 to 2027.
The stroke treatment market in Asia Pacific is expected to expand at a high CAGR of 8 percent during the forecast period.
An effective new treatment is expected to greatly expand the market as no effective medicine is currently available for the treatment of serious stroke like SAH.
A unique and effective drug for SAH is expected to obtain favorable pricing due to the high medical, societal and human cost of the disease.